Evidence map›Paper›PMID 22485150›Full record

ArticlePloS one2012

Regulation of expression of citrate synthase by the retinoic acid receptor-related orphan receptor α (RORα).

Christine Crumbley, Yongjun Wang, Subhashis Banerjee, Thomas P Burris

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. The Encystment-Related MicroRNAs and Its Regulation Molecular Mechanism inInternational journal of molecular sciences · 2020
    Article
  6. Unraveling the Hierarchy ofMolecular and cellular biology · 2020
    Article
  7. Article
  8. Cancer and the Circadian Clock.Cancer research · 2019
    Review
  9. Review
  10. Review
  11. Article
  12. Circadian gene variants in cancer.Annals of medicine · 2014
    Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christine CrumbleyDepartment of Molecular Therapeutics and Center for Diabetes and Metabolic Disease, The Scripps Research Institute, Jupiter, Florida, United States of America.
Yongjun Wang
Subhashis Banerjee
Thomas P Burris
Scripps Research Institute · US

Funding

Development of ROR ligands for treatment of circadian rhythm disordersR01MH092769 · NIMH · ST. LOUIS COLLEGE OF PHARMACY · PI BURRIS, THOMAS P, WALKER, JOHN K. · 2011 to 2020
$6.1M
Regulation of REV-ERBalpha and REV-ERBbeta function of HEMER01DK080201 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI BURRIS, THOMAS P · 2008 to 2012
$1.9M
NIDDK NIH HHS DK080201NIDDK NIH HHS R01 DK080201NIMH NIH HHS MH092769NIMH NIH HHS R01 MH092769
6 · The paper itself

Abstract

The retinoic acid receptor-related orphan receptor α (RORα) is a member of the nuclear receptor superfamily of transcription factors that plays an important role in regulation of the circadian rhythm and metabolism. Mice lacking a functional RORα display a range of metabolic abnormalities including decreased serum cholesterol and plasma triglycerides. Citrate synthase (CS) is a key enzyme of the citric acid cycle that provides energy for cellular function. Additionally, CS plays a critical role in providing citrate derived acetyl-CoA for lipogenesis and cholesterologenesis. Here, we identified a functional RORα response element (RORE) in the promoter of the CS gene. ChIP analysis demonstrates RORα occupancy of the CS promoter and a putative RORE binds to RORα effectively in an electrophoretic mobility shift assay and confers RORα responsiveness to a reporter gene in a cotransfection assay. We also observed a decrease in CS gene expression and CS enzymatic activity in the staggerer mouse, which has a mutation of in the Rora gene resulting in nonfunctional RORα protein. Furthermore, we found that SR1001 a RORα inverse agonist eliminated the circadian pattern of expression of CS mRNA in mice. These data suggest that CS is a direct RORα target gene and one mechanism by which RORα regulates lipid metabolism is via regulation of CS expression.

Indexed as

Gene Expression Regulation, EnzymologicAnimalsBase SequenceBinding SitesCitrate (si)-SynthaseHep G2 CellsHumansLiverMaleMiceMice, Inbred C57BLMice, Neurologic MutantsNuclear Receptor Subfamily 1, Group F, Member 1Promoter Regions, GeneticProtein BindingTranscription, GeneticCitrate (si)-SynthaseNuclear Receptor Subfamily 1, Group F, Member 1RORA protein, human

Identifiers

PMID22485150
PMCPMC3317774
OpenAlexW2055857145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.